Reardon Tighe
Insider CIK 1760431 · THOR Acting Chief Financial Officer · JANX Acting Chief Financial Officer, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 131,196 | $54.75 | $7.18M | 633,673 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 691,525 | $54.75 | $37.86M | 3,340,018 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 157,000 | — | $0 | 157,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2023-11-13 | 2023-11-15 | 849,854 | $5.87 | $4.99M | 849,854 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 110,000 | — | $0 | 110,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 116,750 | — | $0 | 116,750 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 2,105,264 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 900,264 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 2,696,843 | — | $0 | 2,696,843 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 1,153,238 | — | $0 | 3,850,081 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2021-06-15 | 2021-06-16 | 629,411 | $17.00 | $10.70M | 4,479,492 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 30,000 | $57.00 | $1.71M | 0 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 18,723 | $63.36 | $1.19M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 1,682,086 | $68.00 | $114.38M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 43,688 | $68.00 | $2.97M | 0 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,821,156 | — | $0 | 0 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,136,631 | — | $0 | 1,136,631 | SEC↗ |
| THOR Synthorx, Inc. | P Buy | 2018-12-11 | 2018-12-13 | 545,455 | $11.00 | $6.00M | 1,682,086 | SEC↗ |
| THOR Synthorx, Inc. | A Award deriv | 2018-12-06 | 2018-12-07 | 30,000 | — | $0 | 30,000 | SEC↗ |